Add to ORKGhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000268724900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=8e1609b174ce4e31116a60747a720701Biochemical Research MethodsChemistry, MedicinalChemistry, AnalyticalSCI(E)0MEETING ABSTRACTS94-S945
This paper was to design a cyclic RGD (Arg-Gly-Asp) peptide tumor inhibitor with high affinity to in...
Radiolabeled cyclic RGD peptides targeting integrin αvβ3 are reported as promising agents for the ea...
OBJECTIVE: To design a new Arg-Gly-Asp (RGD) peptide that can specifically bind integrin alpha(v)bet...
This report describes the synthesis of two cyclic RGD (Arg-Gly-Asp) conjugates, HYNIC-2PEG(4)-dimer ...
Purpose: The purpose of this study was to demonstrate the valence of cyclic RGD peptides, P-RGD (PEG...
Radiolabeled cyclic RGD (Arg-Gly-Asp) peptides have great potential for the early tumor detection an...
Introduction: Due to the selective expression of the αvβ3 integrin in tumors, radiolabeled arginine...
Contains fulltext : 52604.pdf (publisher's version ) (Closed access)INTRODUCTION: ...
The present study describes the synthesis and biological evaluation of In-111(DOTA-3P-RGD(2)) (DOTA ...
Glioblastoma (GBM) is the most aggressive tumor type in the central nervous system. Both tumor targe...
We have recently developed a series of new Arg-Gly-Asp (RGD) dimeric peptides for specific targeting...
International audienceThe use of multimeric ligands is considered as a promising strategy to improve...
This paper was to design a cyclic RGD peptide tumor inhibitor by molecular docking technique, determ...
We recently developed 125I- and 211At-labeled monomer RGD peptides using a novel radiolabeling metho...
PEGylation typically improves the systemic exposure and tumor biodistribution of polymeric drug deli...
This paper was to design a cyclic RGD (Arg-Gly-Asp) peptide tumor inhibitor with high affinity to in...
Radiolabeled cyclic RGD peptides targeting integrin αvβ3 are reported as promising agents for the ea...
OBJECTIVE: To design a new Arg-Gly-Asp (RGD) peptide that can specifically bind integrin alpha(v)bet...
This report describes the synthesis of two cyclic RGD (Arg-Gly-Asp) conjugates, HYNIC-2PEG(4)-dimer ...
Purpose: The purpose of this study was to demonstrate the valence of cyclic RGD peptides, P-RGD (PEG...
Radiolabeled cyclic RGD (Arg-Gly-Asp) peptides have great potential for the early tumor detection an...
Introduction: Due to the selective expression of the αvβ3 integrin in tumors, radiolabeled arginine...
Contains fulltext : 52604.pdf (publisher's version ) (Closed access)INTRODUCTION: ...
The present study describes the synthesis and biological evaluation of In-111(DOTA-3P-RGD(2)) (DOTA ...
Glioblastoma (GBM) is the most aggressive tumor type in the central nervous system. Both tumor targe...
We have recently developed a series of new Arg-Gly-Asp (RGD) dimeric peptides for specific targeting...
International audienceThe use of multimeric ligands is considered as a promising strategy to improve...
This paper was to design a cyclic RGD peptide tumor inhibitor by molecular docking technique, determ...
We recently developed 125I- and 211At-labeled monomer RGD peptides using a novel radiolabeling metho...
PEGylation typically improves the systemic exposure and tumor biodistribution of polymeric drug deli...
This paper was to design a cyclic RGD (Arg-Gly-Asp) peptide tumor inhibitor with high affinity to in...
Radiolabeled cyclic RGD peptides targeting integrin αvβ3 are reported as promising agents for the ea...
OBJECTIVE: To design a new Arg-Gly-Asp (RGD) peptide that can specifically bind integrin alpha(v)bet...